Long-term Prospective Study of Korean CADASIL Patients

NCT07497867 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-05-14

No results posted yet for this study

Summary

K-CADASIL is a 10-year prospective study of 500 Korean patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a genetic brain disease that causes stroke and dementia. The investigators will track symptoms, brain scans, memory tests, and gene information to understand disease progression in Koreans and identify better treatments. Participants will visit clinics regularly for check-ups and blood tests. This study aims to help improve care for CADASIL patients and families worldwide.

Conditions

  • CADASIL
  • Cerebral Autosomal Dominant Arteriopatie With Subcortical Infarcts and Leukoencephalopathy

Sponsors & Collaborators

  • Asan Medical Center

    collaborator OTHER
  • Chonnam National University Hospital

    collaborator OTHER
  • Chungbuk National University Hospital

    collaborator OTHER
  • Dong-A University Hospital

    collaborator OTHER
  • Ewha Woman University Medical Center

    collaborator UNKNOWN
  • Hallym University Medical Center

    collaborator OTHER
  • Hanyang University Seoul Hospital

    collaborator OTHER
  • Inje University Ilsan Paik Hospital

    collaborator OTHER
  • Kangdong Sacred Heart Hospital

    collaborator OTHER
  • Keimyung University Dongsan Medical Center

    collaborator OTHER
  • Korea University Ansan Hospital

    collaborator OTHER
  • Korea University Guro Hospital

    collaborator OTHER
  • Kyung Hee University Hospital

    collaborator OTHER
  • Kyungpook National University Hospital

    collaborator OTHER
  • Nowon Eulji Medical Center

    collaborator OTHER
  • Pusan National University Hospital

    collaborator OTHER
  • Seoul Medical Center

    collaborator OTHER
  • Seoul National University Bundang Hospital

    collaborator OTHER
  • Seoul National University Hospital

    collaborator OTHER
  • Severance Hospital

    collaborator OTHER
  • Soonchunhyang University Hospital

    collaborator OTHER
  • Ulsan University Hospital

    collaborator OTHER
  • Yeungnam University Hospital

    collaborator OTHER
  • Daejeon Eulji University Medical Center

    collaborator OTHER
  • Jeonbuk National University Hospital

    collaborator UNKNOWN
  • DongGuk University

    collaborator OTHER
  • Jeju National University Hospital

    lead OTHER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-10
Primary Completion
2035-12-31
Completion
2040-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07497867 on ClinicalTrials.gov